-
1
Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
Published 2024-12-01Subjects: Get full text
Article -
2
Immune evasion, infectivity, and membrane fusion of the SARS-CoV-2 JN.1 variant
Published 2025-05-01Subjects: “…Omicron subvariant…”
Get full text
Article -
3
The epidemiology and phylogenetic trends of Omicron subvariants from BA.5 to XBB.1 in Taiwan
Published 2024-11-01Subjects: Get full text
Article -
4
Characteristics of patients with non-severe infections of different SARS-CoV-2 omicron subvariants in China
Published 2024-12-01Subjects: “…omicron subvariant…”
Get full text
Article -
5
Role of booster vaccines and hybrid immunity against severe COVID-19 outcomes during BA.5 omicron predominance in Thailand
Published 2023-12-01Subjects: Get full text
Article -
6
Sublines of Omicron Genovariant of SARS-CoV-2 Virus as Potential Dominant Agents of New Rises of COVID-19 Morbidity in Russia
Published 2024-04-01Subjects: Get full text
Article -
7
Emergence of the SARS-CoV-2 XEC subvariant: public health concerns and preparedness in Nigeria
Published 2025-07-01Subjects: “…SAR-CoV-2 XEC subvariant…”
Get full text
Article -
8
Retrospective Analysis of Omicron in Minas Gerais, Brazil: Emergence, Dissemination, and Diversification
Published 2024-08-01Subjects: Get full text
Article -
9
Antigenic Imprinting Dominates Humoral Responses to New Variants of SARS-CoV-2 in a Hamster Model of COVID-19
Published 2024-12-01Subjects: Get full text
Article -
10
SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors
Published 2023-12-01Subjects: Get full text
Article -
11
-
12
A Clinical and Pathological Comparison of Different Immunomorphological Subvariants of Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma at Initial Diagnosis
Published 2019-03-01Subjects: “…immunohistochemical subvariants…”
Get full text
Article -
13
Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad‐Neutralizing Antibody Response against SARS‐CoV‐2 Omicron Subvariants
Published 2025-07-01Subjects: Get full text
Article -
14
Impaired potency of neutralizing antibodies against cell–cell fusion mediated by SARS-CoV-2
Published 2023-12-01Subjects: Get full text
Article -
15
Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern
Published 2025-04-01Subjects: Get full text
Article -
16
Regional dynamics and mechanisms behind SARS-CoV-2 XDV.1 prevalence in Chongqing via genomic surveillance and molecular insights
Published 2025-05-01Subjects: “…Omicron subvariants…”
Get full text
Article -
17
Neutralization and spike stability of JN.1-derived LB.1, KP.2.3, KP.3, and KP.3.1.1 subvariants
Published 2025-05-01Subjects: Get full text
Article -
18
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants
Published 2023-12-01Subjects: “…SARS-CoV-2 Omicron subvariants…”
Get full text
Article